Market size and opportunity
Sources: IQVIA Institute 2022; DataSUS 2022; Global Cancer Observatory; Citeline; IQVIA Midas, IMF.
Population
|
6th largest
|
214M
|
Pharma market
|
8th largest
|
USD 15B
|
GDP
|
10th largest
|
USD 1,8T
|
New cancer cases per year
|
6th largest
|
600,000
|
Number of oncologists
|
3th largest
|
8,500
|
Participation in clinical studies
|
19th
|
|
Data for global cancer studies
|
2%
|
Despite its huge population, the amount of new cancer cases per year, and having the 3rd largest number of oncologists in the world, Brazil only ranks 19th in participation in clinical studies and contributes with only 2% of all data used in global oncology studies.
The two main reasons for such poor participation:
• Lack of specialized software to collect cancer data.
• Lack of high quality structured data sets for oncology.